Skip to main content

Table 2 Antibodies used in the study

From: Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy

Name

Source

Dilution

Anti-cytokeratin 18 (K18)

Santa Cruz Biotechnology, Santa Cruz, CA

1:200

Anti-AR

BD Pharmingen, San Diego, CA

1:200

Anti-PSA

Santa Cruz Biotechnology

1:100

Anti-AMACR/p63

Biocare, Concord, CA

ready to use

Anti-Ki67

Biocare

1:100

Anti-Ku70

Abcam, Cambridge, MA

1:200

Anti-human specific-CD31

Dako Corp., Carpinteria, CA

1:20

Anti-CCNA

Leica Microsystems, Buffalo Grove, IL

1:50

Anti-ERG

Epitomics, Burlingame, CA

1:100

Anti-VIM

Epitomics

1:100

Anti-TOP2A

Dako Corp

1:50

universal biotinylated horse anti-mouse/rabbit IgG

Vector Laboratories Inc., Burlingame, CA

1:1000

Alexa 488 goat anti-mouse

Invitrogen, Carlsbad, CA

1:1000

Alexa 555 goat anti-rabbit

Invitrogen

1:1000